Search by Drug Name or NDC
NDC 65162-0914-46 Tobramycin 300 mg/5mL Details
Tobramycin 300 mg/5mL
Tobramycin is a RESPIRATORY (INHALATION) SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is TOBRAMYCIN.
Product Information
| NDC | 65162-0914 |
|---|---|
| Product ID | 65162-914_3a3ef4b7-6b70-453d-be8c-dd921d46d4c6 |
| Associated GPIs | 07000070002520 |
| GCN Sequence Number | 037042 |
| GCN Sequence Number Description | tobramycin in 0.225% sod chlor AMPUL-NEB 300 MG/5ML INHALATION |
| HIC3 | W1F |
| HIC3 Description | AMINOGLYCOSIDE ANTIBIOTICS |
| GCN | 61551 |
| HICL Sequence Number | 016926 |
| HICL Sequence Number Description | TOBRAMYCIN IN 0.225 % SODIUM CHLORIDE |
| Brand/Generic | Generic |
| Proprietary Name | Tobramycin |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Tobramycin |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION |
| Route | RESPIRATORY (INHALATION) |
| Active Ingredient Strength | 300 |
| Active Ingredient Units | mg/5mL |
| Substance Name | TOBRAMYCIN |
| Labeler Name | Amneal Pharmaceuticals LLC |
| Pharmaceutical Class | Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA205501 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 65162-0914-46 (65162091446)
| NDC Package Code | 65162-914-46 |
|---|---|
| Billing NDC | 65162091446 |
| Package | 56 AMPULE in 1 CARTON (65162-914-46) / 5 mL in 1 AMPULE |
| Marketing Start Date | 2014-07-13 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 2.08139 |
| Pricing Unit | ML |
| Effective Date | 2024-02-21 |
| NDC Description | TOBRAMYCIN 300 MG/5 ML AMPULE |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis